Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.

Esther N D KokK HavengaP J TanisJ H W de WiltJ HagendoornF P PetersJ BuijsenH J T RuttenK F D Kuhlmannnull null

Published in: The British journal of surgery (2020)

Multimodal treatment leads to relief of symptoms in most patients, and is associated with good survival rates in those able to complete the schedule. [Correction added on 12 February 2020, after first online publication: the Conclusion has been reworded for clarity].

Keyphrases

rectal cancer
end stage renal disease
locally advanced
ejection fraction
chronic kidney disease
newly diagnosed
early stage
radiation therapy
social media
pain management
healthcare
depressive symptoms
sleep quality
patient reported outcomes
catheter ablation